Toxic Effects of Intracerebral PrP Antibody Administration During the Course of BSE Infection in Mice
Maxime Lefebvre-Roque(Scripps Research Institute), Corinne Ida Lasmézas(Scripps Research Institute), Hermann Schätzl(University of Calgary), Chantal Mourton-Gilles(Scripps Research Institute), Cécile Feraudet‐Tarisse(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Sabine Gilch(University of Calgary), Elisabeth Kremmer(Justus-Liebig-Universität Gießen), Thierry Baron(Physiopathologie, diagnostic et traitements des maladies musculo-squelettiques), Nicole Salès, Wen‐Quan Zou(Jiangxi Provincial Academy of Medical Sciences), Jacques Grassi(Universidade Federal do Espírito Santo), Pierluigi Gambetti(Case Western Reserve University)
HAL (Le Centre pour la Communication Scientifique Directe)
January 1, 2007
Cited by 4
Related Papers
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
|Annals of Neurology|1999|1.4k
Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease
|Annals of Neurology|1996|876
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay
|Analytical Chemistry|1985|707
Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells
|Journal of Biological Chemistry|2004|330
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
|Proceedings of the National Academy of Sciences|2009|299